ENTITY
Grifols

Grifols (GRFS US)

41
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
•18 May 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: May '26 Report

European dual-class spreads tightened again in May as liquidity-driven convergence resumed. Handelsbanken, MFE and Telecom Italia led compression,...

Share
•17 Apr 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: April '26 Report

European dual-class spreads re-widened in April, with mean rising on right-tail moves. Liquidity-driven convergence persists, while structural...

Share
bullish•FUCHS (Pref)
•17 Mar 2026 22:04

Liquid Universe of European Ordinary and Preferred Shares: March '26 Report

March saw convergence across European dual-class shares, with dispersion narrowing as liquidity returned. Structural outliers persist, while...

Share
bullish•Danieli
•17 Feb 2026 21:12

Liquid Universe of European Ordinary and Preferred Shares: February '26 Report

February brought mild widening in Europe’s dual-class spreads, but no systemic repricing of voting rights. Dispersion remains driven by structural...

Share
•19 Jan 2026 13:45

Liquid Universe of European Ordinary and Preferred Shares: January '26 Report

January confirmed dispersion without repricing in European dual-class stocks: liquidity and structure drove selective convergence, while a few...

Share
x